948018-61-9 Usage
Uses
Used in Pharmaceutical Industry:
2-Fluoro-4-(4-Methyl-1-piperazinyl)benzoic Acid is used as a building block for the synthesis of pharmaceutical compounds due to its unique chemical structure and potential to interact with specific biological targets.
Used in Medicinal Chemistry Research:
2-Fluoro-4-(4-Methyl-1-piperazinyl)benzoic Acid is utilized as a research tool in medicinal chemistry to explore its interactions with biological targets and understand its mechanism of action, which aids in the development of new therapeutic agents.
Used in Drug Development:
2-Fluoro-4-(4-Methyl-1-piperazinyl)benzoic Acid is employed in drug development for the treatment of various medical conditions, leveraging its ability to act as a ligand for specific biological targets, although the exact therapeutic effects and mechanisms are still under investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 948018-61-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,8,0,1 and 8 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 948018-61:
(8*9)+(7*4)+(6*8)+(5*0)+(4*1)+(3*8)+(2*6)+(1*1)=189
189 % 10 = 9
So 948018-61-9 is a valid CAS Registry Number.
948018-61-9Relevant academic research and scientific papers
SUBSTITUTED PYRAZOLO [4,3-C] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS
-
Page/Page column 98, (2008/06/13)
Substituted pyrazolo[4,3-c]pyridine derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a dysregulated protein kinase activity, like cancer.
BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS
-
Page/Page column 54, (2008/06/13)
A compound having formula (I): wherein: R, A, R1 and R2, are as defined in the specification, and pharmaceutical formulas thereof, and methods of use thereof
